Timothy Ken and John Lem headshots

Psychedelics and the future of treating substance abuse with John Lem and Timothy Ko

Céline Williams |

Entheon Biomedical CEO Timothy Ko and John Lem, the founder of Lobo Genetics are singular in their mission to research genetic driven approaches to developing personalized tools for use in psychedelic-assisted therapeutic treatments for substance use disorders.

With firsthand knowledge of the shortcomings of the current treatment system, Ko, and Lem, the developer behind a direct-to-consumer platform being used in HaluGen’s Psychedelic Genetics test kit, the two are working together to find the right solutions for patients faster and improve outcomes.

Entrepreneurs are the backbone of Canada’s economy. To support Canada’s businesses, subscribe to our YouTube channel and follow us on FacebookInstagramLinkedIn and Twitter.

Want to stay up-to-date on the latest #entrepreneur podcasts and news? Subscribe to our bi-weekly newsletter

Related Podcasts

Entrepreneurship is the relentless pursuit of opportunity

Purya Sarmadi is a healthcare professional with an accomplished background in healthcare technology. He is a health informatics and...

Read More

Exploring the Transition: From Corporate to Entrepreneurial Drive

Kim Tabac is a dynamic business executive with over 25 years of experience designing and executing people & culture...

Read More

Using Art to Change the World with Craig Perlmutter of Arcadia Earth

Craig Perlmutter is the president of Arcadia Earth Toronto. His detail-oriented, hands-on leadership merged with enthusiasm toward the outdoors,...

Read More

Join Our Newsletter

Subscribe to receive info on our latest news and episodes